Health Care News and Research

RSS

FDA issues warning over faulty components in external defibrillators

About 280,000 external defibrillators used worldwide in health care facilities, public places, or in the home may malfunction during attempts to rescue people in sudden cardiac arrest, the U.S. Food and Drug Administration warned today.

28 Apr 2010

Companies providing home care receive large Medicare reimbursements

An analysis of Medicare payments to home health care companies by The Wall Street Journal indicates that some might be taking advantage of the system. According to the analysis, the industry's largest company, Amedisys Inc., "provided many of its patients just enough therapy visits to trigger the extra $2,200 payment.

28 Apr 2010

Commission on debt will focus on Medicare, Medicaid, Social Security

Lawmakers are prepping for a battle over the role of government in entitlements such as Medicare and Medicaid as a the Commission on Fiscal Responsbility and Reform prepares to begin work Tuesday, The Washington Post reports.

28 Apr 2010

Report looks at AIDS funding in developing countries

"A global pullback on commitments to fund and fight AIDS is resulting in restrictions on the number of people being enrolled into treatment programmes, more frequent drug shortages, and reduced national AIDS budgets," according to a report released Monday by the International Treatment Preparedness Coalition, BMJ News reports.

28 Apr 2010

News outlets continue malaria coverage

World Malaria Day was Sunday and news organizations continued to cover local events.

28 Apr 2010

Ontario seniors stand against McGuinty government's $750M cuts to front-line healthcare

The Alliance of Seniors/Older Canadians Network, an organization of approximately 20 seniors organizations, representing in excess of 200,000 seniors across Ontario, along with concerned seniors from our communities, have come out today to stand against the McGuinty government's $750M cuts to front-line healthcare.

28 Apr 2010

Moody's report: States will feel pinch of reform's Medicaid, health care expansions

"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."

28 Apr 2010

Doctors struggle to contact ER patients as departments bear larger patient burden

MSNBC: Doctors in ERs face significant barriers in providing the best care when phone numbers that patients give turn out to be fake or inaccurate. "It's a scenario becoming more common in emergency departments across the country, where doctors from Connecticut to Colorado say they find themselves desperately seeking patients with potentially serious or life-threatening illnesses and injuries.

28 Apr 2010

House lawmaker discusses possible five-year Medicare physician payment fix

Rep. Chris Van Hollen, D-Md., said the House might introduce legislation that would end the need for a constant Medicare payment fix, at least for five years. "Industry sources said that a five-year extension would not require offsets under recent pay-as-you-go rules. However, they said they were not aware of any legislative proposals.

28 Apr 2010

CNN: Hospital markup on supplies can be big

CNN: "When Dr. Linda Galloway learned she needed surgery to save her vision, she scheduled the procedure immediately with her opthamologist. And what an eye-opener it was - when the hospital bill arrived."

28 Apr 2010

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.

28 Apr 2010

Experts debate rationing and end-of-life care; Hospice use rises in Colorado

PBS NewsHour reports on end-of-life decisions and rationing by examining a recent debate at the University of Virginia's Miller Center of Public Affairs. "Arguing for rationing: Ira Byock, a doctor and director of palliative medicine at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and Arthur Caplan, director of the Center for Bioethics and a professor at the University of Pennsylvania.

28 Apr 2010

Gangs increasingly involved in Medicare fraud

ABC News: "Gangs across the country are arming themselves with powerful weapons to bilk taxpayers out of billions of dollars through Medicare fraud. What used to be a mostly non-violent, white collar crime has turned potentially deadly, and Federal agents who once combed through paperwork are now firing rounds at the shooting range to prepare for extreme dangers.

28 Apr 2010

DRCR Network study finds new treatment more effective

28 Apr 2010

Fine print complicates effort to cover young adults

Some parents may have to wait to get children as old as age 26 to be allowed to stay on their health plans because of the health law's fine print, The Associated Press reports. "As a consequence, some families may have to wait until 2011 to get their kids covered, particularly if the parents are working for a large employer, benefits experts and government officials say.

28 Apr 2010

As health reform's specifics continue to emerge, so do questions and answers from stakeholders

Determining how the law will be applied will be the next big battle in health reform and lobbyists are gearing up to influence implementation. "Congress gave sweeping power to federal agencies, especially (HHS), to fill in gaps lawmakers left in the 906-page legislation — an effort that will take years. The law refers more than 1,000 times to Cabinet secretaries who will make decisions on how to carry out the law. For example, the law requires insurance companies to spend 80% of premiums on medical claims, as opposed to administrative costs, by 2011. But it directs the health department to decide whether gray-area expenses, such as health-and-wellness programs offered by insurers, count as care or overhead."

28 Apr 2010

A bitter pill to swallow

Reporting for Kaiser Health News in collaboration with The Washington Post, Sandra Boodman writes: "When Jere Carpentier learned last year that she had advanced colon cancer -- her third malignancy in a dozen years -- she worried about spending hours in a clinic tethered to an intravenous line, enduring punishing chemotherapy that would make her hair fall out.

28 Apr 2010

States uneasy about impact of Medicaid expansion

The expansion of insurance coverage under the health reform law is due largely to an expansion of the government-funded Medicaid program, which is causing some doctors to worry about the specifics of implementation, according to the New York Times. "Absorbing that many people into the system will not be easy. The program is administered and partly financed by the states, which are now racing to figure out how to carry out the necessary changes and simplify enrollment even as they struggle to cope with severe budget cuts and staff shortages."

28 Apr 2010

Better vision ahead for many diabetic retinopathy patients

A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.

27 Apr 2010

Expensive generic drugs cost Australia billions

Consumers and the Australian Government are paying up to 10 times more for generic cholesterol-lowering drugs compared to the United Kingdom, according to research carried out by health economists at the University of Sydney.

27 Apr 2010